In the case of medicinal products where the active substance is well-known, the workload related to their monitoring is smaller than in the case of products with a completely new chemical entity.
In the case of medicinal products where the active substance is well-known, the workload related to their monitoring is smaller than in the case of products with a completely new chemical entity.